In today s Research Roundup for March 21, 2022, we highlight some of the most interesting reads in global health research and development from the past week.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform a technology used in several approved COVID-19 vaccines.